Valion Bio (VBIO) CEO converts 2,206 RSUs, now holds 11,030 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Valion Bio, Inc.’s Chief Executive Officer Michael K. Handley exercised restricted stock units into common shares. On May 18, 2026, he acquired 2,206 shares of common stock through a derivative exercise recorded at $0.00 per share.
Following the transaction, he directly holds 11,030 shares of common stock and 24,265 restricted stock units. Each restricted stock unit converts into one share of common stock under a multi‑year vesting schedule described in the grant terms.
Positive
- None.
Negative
- None.
Insider Trade Summary
2,206 shares exercised/converted
Mixed
2 txns
Insider
Handley Michael K
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,206 | $0.00 | -- |
| Exercise | Common Stock | 2,206 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 24,265 shares (Direct, null);
Common Stock — 11,030 shares (Direct, null)
Footnotes (1)
- Each Restricted Stock Unit is convertible into one share of common stock. Twenty percent (25%) of the grant of 35,294 Restricted Stock Units vested upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Shares acquired via RSU exercise: 2,206 shares
Post-transaction common shares: 11,030 shares
Post-transaction RSU balance: 24,265 RSUs
+2 more
5 metrics
Shares acquired via RSU exercise
2,206 shares
Common Stock acquired on May 18, 2026
Post-transaction common shares
11,030 shares
Common Stock directly held after exercise
Post-transaction RSU balance
24,265 RSUs
Restricted Stock Units remaining after conversion
RSU exercise price
$0.00 per share
Recorded transaction price for RSU conversion
Original RSU grant size
35,294 RSUs
Restricted Stock Unit grant subject to four-year vesting
Key Terms
Restricted Stock Units, derivative exercise/conversion, vesting commencement date, quarterly installments, +1 more
5 terms
Restricted Stock Units financial
"Twenty percent (25%) of the grant of 35,294 Restricted Stock Units vested upon the one (1) year anniversary..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion", transaction_code_description: "Exercise or conversion of derivative security""
vesting commencement date financial
"the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units..."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
quarterly installments financial
"the balance of the Restricted Stock Units will be vested in a series of twelve (12) successive equal quarterly installments..."
common stock financial
"Each Restricted Stock Unit is convertible into one share of common stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did Valion Bio (VBIO) report for Michael K. Handley?
Valion Bio reported that CEO Michael K. Handley exercised restricted stock units into common shares. On May 18, 2026, he acquired 2,206 shares of common stock via a derivative exercise, a compensation-related event rather than an open-market purchase or sale.
What type of security did the Valion Bio (VBIO) CEO exercise on this date?
The CEO exercised restricted stock units that convert into Valion Bio common stock. The Form 4 shows 2,206 restricted stock units being converted, with each unit becoming one common share, consistent with the grant’s terms described in the accompanying footnotes.
Was the Valion Bio (VBIO) CEO’s Form 4 transaction a market buy or sell?
The Form 4 reflects a derivative exercise, not an open-market buy or sell. Michael K. Handley acquired 2,206 common shares by converting restricted stock units, recorded at a transaction price of $0.00 per share as part of his equity compensation.
What does the vesting schedule for Valion Bio (VBIO) restricted stock units indicate?
The footnotes explain that a grant of 35,294 restricted stock units vests over four years. An initial portion vests on the first anniversary of the vesting commencement date, with the remaining units vesting in twelve successive equal quarterly installments thereafter.
How many restricted stock units remain for the Valion Bio (VBIO) CEO after this transaction?
Following this derivative exercise, the Form 4 shows Michael K. Handley holding 24,265 restricted stock units. Each remaining unit is convertible into one share of Valion Bio common stock, subject to the time-based vesting schedule outlined in the grant’s terms.